Aim: To perform a meta-analysis to assess whether the presence of cancer-associated fibroblasts (CAF) is a prognostic marker of oral squamous cell carcinomas (OSCC).
treatment plans, and post-therapeutic monitoring are urgently required.
During OSCC invasion, tumor cells induce a series of modifications in the adjacent stroma, promoting a unique environment (commonly termed the tumor microenvironment) composed of an extracellular matrix scaffold, vascular structures, and cellular components including adipocytes, muscle cells, mast cells, immune and inflammatory cells, and fibroblasts. Some fibroblasts acquire an activated phenotype and are termed cancer-associated fibroblasts (CAF; also known as peritumoural fibroblasts, activated fibroblasts, or myofibroblasts). 4 CAF are thought to have a variety of origins, including transformation from resident fibroblasts, epithelial cells, and pericytes or differentiation from mesenchymal stem cells. 5 There is no specific marker for CAF, but alpha smooth muscle actin (a-SMA) is the most used and reliable marker for detecting CAF. 6 CAF are found in approximately 60% of OSCC, frequently in close contact with the tumor islands, 7, 8 but are not found in tumor-free tissues and in the adjacent stroma of potentially malignant disorders of the oral mucosa. 9 Moreover, in vitro studies have demonstrated that transforming growth factor beta (TGF-b) released by oral carcinoma cells induces CAF activation, 8, 10 suggesting that the emergence of CAF within tumor microenvironment is influenced by tumor cell invasion.
Previous studies have demonstrated that increased density of CAF in the stroma of OSCC correlated with higher mortality. 7, 11, 12 Further analyses revealed that CAF promote tumorigenesis of OSCC cell lines via an enriched and specific secretome, which contains activin A, fibronectin type III domain-containing 1 (FNDC1), serpin peptidase inhibitor type 1 (SERPINE1), stanniocalcin 2 (STC2), among other proteins putatively related to tumorigenesis. 13, 14 Importantly, Marsh and collaborators 12 provided evidence that the presence of CAF in the stroma of OSCC is a stronger predictor of mortality than the classical TNM staging. However, other studies did not find a significant association between CAF and survival of patients with OSCC. 15 , 16 The aim of this systematic review and meta-analysis was to verify the value of CAF for the prognosis of patients with OSCC.
The present study provides evidence that immunohistochemical detection of CAF (a-SMA-positive fibroblasts) is an independent marker of shortened disease-free survival (DFS) and poor overall survival (OS) in patients with OSCC.
| MATERIALS AND METHODS
This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist as described in Moher et al. 17 
| Protocol and registration
The review was registered at the international prospective register of systematic review (http://www.crd.york.ac.uk/PROSPERO/) and received the number CRD42017060787 (http://www.crd.york.ac.uk/ PROSPERO/display_record.asp?ID=CRD42017060787).
| Study design
The systematic review and meta-analysis of human studies were undertaken to evaluate whether immunodetection of CAF (a-SMApositive fibroblasts) serves as a prognostic factor of the survival of patients with OSCC. 
| Exclusion criteria
Studies were excluded for the following reasons: (i) studies that did not fit PICOS strategy; (ii) reviews, letters, personal opinions, book chapters, and conference abstracts.
| Information sources and search strategy
Search strategies in the Cochrane, LILACS, PubMed, Scopus, and
Web of Science databases included the following terms: "oral squamous cell carcinoma" OR "OSCC" OR "oral cancer" OR "oral cancers"
OR "mouth neoplasms" (MeSH Terms) OR "mouth neoplasm" OR "oral neoplasm" OR "oral neoplasms" OR "cancer of mouth" OR "mouth cancers" OR "mouth cancer" OR "cancer of the mouth" OR "tongue cancer" OR "squamous cell carcinoma of the oral cavity" OR "tongue squamous cell carcinoma" OR "tongue squamous cancer"
AND "cancer-associated fibroblast" OR "carcinoma-associated fibroblast" OR "CAF" OR "peritumoural fibroblast" OR "activated fibroblast" OR myofibroblast OR myofibroblasts.
The search was conducted on April 02, 2017. A partial gray literature search was also performed using Google Scholar and ProQuest. The selected references were checked and managed by a reference manager software (EndNote, Thomson Reuters, New York, NY, USA). In addition, the reference lists of the selected articles were hand-screened for potentially relevant studies that could have been missed during the electronic database searches.
| Study selection
The articles were selected in two phases. In phase 1, two authors (MRD and RDC) independently reviewed the titles and abstracts, and selected those that apparently met the inclusion criteria. In phase 2, the same authors read the full texts of the selected articles at phase 1 and excluded those that did not meet the inclusion crite- 
| Risk of bias in individual studies
Methodologically, the authors appraised all of the included studies according to a checklist based in Meta-Analysis of Statistics Assessment and Review Instrument (MAStARI). 18 Two reviewers (MRD and RDC) answered 9 questions for descriptive studies as Y for "yes," N for "no," U for "unclear," and NA for "not applicable". After that, the risk of bias was categorized as high when the study reached up to 49% of a "yes" score, moderate when the study reached 50%-69%
of a "yes" score, and low when the study reached more than 70% of a "yes" score. Disagreements were solved by discussion between the three authors (MRD, RDC, and ENSG).
| Measures for meta-analysis
The OS and DFS meta-analysis was performed following the appro- 
| Study characteristics
The selected studies were published between 2007 and 2017 and were all written in English. England, 12, 31 Croatia, 27 and Norway. 32 In addition, 2 studies were performed in collaboration, 1 between Finland and Israel 11 and 1 between Brazil and Finland. 33 The selected articles were observational studies. The main features and findings of the studies are presented in Table 1 . (Table S1 ). Regarding the risk of bias across studies, the selected studies used similar methods, which reduced the possibility of
| Risk of bias
misinterpretation. These studies were suitable for grouping for metaanalysis, and two different subgroups, based on the outcome, were generated.
| Correlation between CAF and clinicopathological characteristics
Although there was no standard score system to assess CAF density in the stroma of the tumors, all studies reported some positive relationship between presence of CAF and clinicopathological features of tumors. The main findings of each study are described in Table 1 .
CAF were identified in the stroma of OSCC for the first time by cally confirmed lymph node metastasis, and extracapsular lymph node spread. 7 At the invasive front, density of CAF was also associated with perineural invasion. The univariate analysis for OS showed that patients with abundance of CAF at the invasive front had significantly poorer OS rate than those with negative or low frequency of CAF. 7 No association with DFS was observed. The same group confirmed in a second study the association between presence of CAF and parameters of OSCC aggressiveness. 8 Presence of CAF was significantly correlated with N stage, disease stage, and cervical relapse In a study with 178 tongue squamous cell carcinomas, Li et al 26 showed a significant association between high density of CAF and pathologic stage, T classification, N classification, and recurrence.
The survival curves showed that the frequency and the distribution of CAF were significantly associated with a poor OS and DFS, but multivariate analysis showed that the presence of CAF was an independent predictor only for shortened OS.
Luksic et al 27 found that a high density of CAF in OSCC is asso- Eleven studies reported data regarding the association between CAF levels and OS. 11, 12, 14, 15, 21, [23] [24] [25] [26] [27] [28] Six studies 11, 12, 23, 24, 26, 27 found that the presence of CAF is a significant marker for OS. Three stud- | 449
| Disease-Free Survival
Four studies were evaluated for DFS. 14, 22, 23, 28 As shown in Figure 3 , the pooled HR derived from multivariate analyses was 3.32 (95% CI:
2.09-5.26, P for heterogeneity = 0.50, I 2 = 0%), indicating that patients with high density of CAF demonstrated worse DFS. Three of the studies 14, 22, 23 found significant association between density of CAF and increased relapse of disease after initial treatment.
| Level of evidence
Based on GRADE analysis, the quality of the evidence for both OS and DFS studies was moderate, suggesting a moderate confidence in estimating the outcomes. The moderate risk of bias in most studies was the main factor responsible for the limited quality of evidence (Data S1).
| DISCUSSION
The biological properties and functions of CAF in tumor progression and metastasis have been extensively reported in several studies. This study has some limitations. First, although against the same epitope (1A4), antibodies from different companies were used; this may lead to differences in the quality and intensity of staining results. Second, no method or cutoff definition has been accepted and validated for evaluating CAF density. Indeed, several different systems were applied to group tumors containing low or high density of CAF. Third, the sample size was limited and we were obligated to exclude some studies of the meta-analysis because they did not perform multivariate analysis or did not report the adjusted HR and 95% CI. These could have been estimated from the survival curves, but we elected not to do because this approach could induce heterogeneity and bias in the results. Fourth, the clinical heterogeneity across the studies, including differences on tumor site, tumor stage, and other clinicopathological features, was profound. Furthermore, assessment and adjustment of confounders differed among the studies. Finally, although we have adopted random-effects model for OS because moderate heterogeneity was detected, the inherent F I G U R E 3 The density of CAF is an independent risk factor for relapse of the disease (disease-free survival-DFS). 
